the structure was secured by a direct comparison with an authentic sample synthesized from tropolone. BMY-28438exhibited weak activity against a variety of Gram-positive and Gram-negative bacteria and fungi, and strong cytotoxicity against B16 melanoma cells. It produced significant prolongation of survival time of mice transplanted with B16 melanoma, but no antitumor activity was observed against P388 leukemia. This report describes production, isolation, physico-chemical and biological properties and structure of BMY-28438.
Antibiotic Production A loopful of S. tropolofaciens No. K611-97, taken from a mature slant culture was inoculated into a 500-ml Erlenmeyer flask containing 100 ml of a seed medium consisted of soybean meal 3%, corn starch 2%, MgSO4-7H2O0.33% and CaCO3 1 %, the pH being adjusted to 7.0 before sterilization. The flask was then incubated at 28°C for 4 days on a rotary shaker (200rpm) and 5 ml of the culture was transferred into 500-ml Erlenmeyer flask containing 100 ml of a fermentation medium having the same composition as the seed medium.The fermentation was carried out at 28°C for 6 days on a rotary shaker. The antibiotic production was monitored by the paper-disc agar diffusion method against Cryptococcus neoformans IAM4514 as the test organism. For a large scale production, the fermentation studies were carried out in the stainless steel fermentors. The seed culture was prepared in twenty 500-ml Erlenmeyer flasks incubated at 32°C for 4 days on a rotary shaker. The resultant culture was transferred into a 200-liter tank fermentor containing 120 liters of a production medium. The seed and production media consisted of soybean meal 3%, glucose 3%, Pharmamedia 0.5%, yeast extract 0.1 % and CaCO3 0.3 %. Tank fermentation was carried out at 28°C with stirring at 250 rpm and aeration at 120 liters/minute. The production reached a maximumafter 115 hours.
Isolation and Purification
The cultured broth (208 liters, pH 9.06) was separated into the mycelial cake and the supernate with the aid of a continuous centrifuge (Kokusan H-600). The supernate (pH 9.0) was passed through a column of Diaion HP-20 (10 liters) to adsorb some impurities. The passed supernate was adjusted to pH 4.0 with 6n HC1 and applied again on a Diaion HP-20 column (15 liters).
After washing with water (20 liters), the column was developed with a mixture of acetone -0.1 n NH4OH(1 : 1, 40 liters)., The eluate was monitored by in vitro cytotoxicity against B16 melanoma cells and paper-disc assay against C. neoformans IAM4514.
The active fractions were pooled and evaporated in vacuo to afford 370g of crude solid. A 37-g sample of this solid was charged on a columnof Sephadex G-25 (8.0 x 110 cm, 5 liters) which was developed with water. Evaporation of the active fractions gave a semi-pure sample of BMY-28438 (21 mg). The solid was further chromatographed on Sephadex 100ml ) with methanol elution to yield a nearly homogeneous i in ppm (DMSO-d6). 
Physico-chemical Properties
BMY-28438is weakly acidic, and readily soluble in dimethylformamide and dimethyl sulfoxide, slightly soluble in water, methanol and ethanol but practically insoluble in other organic solvents. It showed positive response to ferric chloride and negative to ninhydrin, anthrone and Fehling reaction, BMY-28438crystals did not exhibit definite mp and gradually sublimed over 170°C. The molecular formula of C7H6O4was assigned for the antibiotic based on its high resolution mass spectral (HR-MS) data (M+ m/z 154.0232) and microanalysis.
The antibiotic exhibited strong UV absorption at 273, 340 (sh), 351 and 359 nm in ethanol, at 265, 329 and 366 nm in acidic ethanol and at 224, 283, 340 and 354 nm in alkaline ethanol (Fig. 1) . The physico-chemical data of BMY-28438are summarized in Table 1 , and IR spectrum in KBr pellet is shown in Fig. 2 .
Structural Studies BMY-28438was given the molecular formula of C7H6O4by mass spectrum and microanalysis. The HR-MSproduced strong fragment ions caused by loss of CO and H2O from the molecular ion: m/z 126.0294 (M+-CO), m/z 108.0170 (M+-CO-H2O) and m/z 80.0273 (M+-2CO-H2O). The IR spectrum exhibited strong absorption at 3490, 1590, 1520, 1410, 1210 and 1180cm"1. The *H NMRshowed only one signal at 7.02 ppm (br s) and the 13C NMRfour carbon signals at 117.5, 127.1, 156.5 and 156.7 ppm indicating a tautomeric structure.
These data combined with its characteristic UVspectrum strongly suggested 3,7-dihydroxytropolone2) for BMY-28438. In order to confirm the proposed structure, 3,7-dihydroxytropolone was synthesized by persulfate oxidation of tropolone3). The reaction mixture was subjected to a Craig counter-current distribution machine (chloroform -toluene -methanol -H2O, 15 : 15 :23 :7) and 3,7-dihydroxytropolone was separated from coproduced 5-hydroxy, 7-hydroxy and 4,7-dihydroxy analogs. It was further purified by Sephadex LH-20 chromatography to a homogeneous sample. BMY-28438was identical with 3,7-dihydroxytropolone synthesized in all respects.
Biological Properties
In Vitro Antimicrobial Activity The MICs of BMY-28438were determined against various bacteria and fungi by the 2-fold agar dilution method. Tropolone and two tropolone derivatives, 7-hydroxy and 4,7-dihydroxytropolones coproduced in the synthesis of 3,7-dihydroxytropolone were comparatively tested. Nutrient agar mediumwas used for Gram-positive and Gram-negative bacteria and Sabouraud dextrose agar mediumfor fungi. As shown in Table 2 , BMY-28438 showed very weak inhibitory activity against Gram-positive and Gram-negative bacteria, while tropolone and 7-hydroxytropolone4) showed much higher activity against Gram-positive bacteria.
In contrast to 3,7-dihydroxytropolone, 4,7-dihydroxytropolone did not show activity against all test strains. BMY-28438exhibited significant activity against fungi, whereas other analogs were nearly inactive.
In Vitro Cytotoxicity and Inhibition of Macromolecule Biosynthesis BMY-28438,tropolone and hydroxytropolones were tested for in vitro cytotoxicity against logarithmically growing murine B16-F10 melanoma cells in suspension culture. B16-F10 cells (4 x 104 cells) in the enriched Eagle's minimum essential medium containing 10 % calf serum and the test samples solution were planted into the wells of 96-well microtiter plates and incubated at 37°C for 72 hours with 5 % CO2under high humidity condition. After staining with neutral red, cytotoxicity of the test samples was determined colorimetrically.
As shown in Table 3 , BMY-28438showed the most potent cytotoxicity followed by 7-hydroxytropolone, 4,7-dihydroxytropolone, tropolone and 5-hydroxytropolone. BMY-28438was about 8~60 times more cytotoxic than tropolone and the hydroxytropolones. The inhibitory effects on macromolecule biosynthesis were examined in cultured L1210 leukemia cells. L1210 cells (5 x 105 cells) were exposed to radioactive precursors ([me^/-3H]thymidine 0.05 AtCi/ml, [2-14C] uridine 0.05 /^Ci/ml and L-[4,5-3H]leucine 0.2^Ci/ml) for 60 minutes after treatment with each test compound for 15 minutes in the above medium. The incorporated radioactivities into the acid-insoluble fraction were measured by using a liquid scintillation counter and the results were shown in Table 3 . BMY-28438 showed non-specific inhibitory effects on DNA, RNAand protein biosynthesis with the IC50 values of 9 to 14^g/ml.
In Vivo Antitumor Activity
The antiturnor activity of BMY-28438was determined in male BDFXmice against P388 leukemia and B16 melanoma. P388 leukemia and B16 melanoma were inoculated by the intraperitoneal injection at 106 cells and 0.5 ml of a 10%-tumor brei per mouse, respectively. Test material was administered to mice intraperitoneally once daily through 1 to 9 days after tumor implantation. Tropolone and mitomycin C were comparatively tested in the experiments. As shown in Table 4 , BMY-28438 exhibited significant prolongation of life span in mice bearing B16 melanoma, while no activity was observed against P388 leukemia. Tropolone was inactive against B16 melanomaeven at the maximum dose tested.
Discussion
A new actinomycete strain, S. tropolofaciens No. K61 1-97 produced a new antitumor antibiotic BMY-28438. The antibiotic isolated from the fermentation broth was identified as 3,7-dihydroxytropolone by a direct comparison with the authentic sample synthesized. 3,7-Dihydroxytropolone has been synthesized previously2»3), but this is the first example of the isolation of 3,7-dihydroxytropolone from the natural source. Several natural and synthetic tropolones have been found to show antitumor activity against P388 murine leukemia5~9). However, the antitumor activity of 3,7-dihydroxytropolone has never been reported. It should particularly be noted that BMY-28438exhibited antitumor activity against B16 melanoma in mice but it was inactive against P388 leukemia. Other hydroxytropolones and tropolone did not exert antitumor effect on B16 melanoma in our test. It is interesting that, unlike other tropolone derivatives, BMY-28438showed only weak activity against bacteria and fungi, but strong cytotoxicity against B16 melanomacells. These observations make BMY-28438, 3,7-dihydroxytropolone, distinct in the hydroxytropolone derivatives so far tested and justify further investigation on its antitumor activity and preparation of its analogs.
